CFO appointment
DENTSPLY SIRONA Inc. appoints John C. Fortson as CFO
DENTSPLY SIRONA Inc. reported in a Form 8-K filed June 11, 2026 that John C. Fortson was appointed Executive Vice President & Chief Financial Officer, effective July 20, 2026.
In the filing's words
On June 1, 2026, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed John C. Fortson as the Company’s Executive Vice President & Chief Financial Officer, effective as of July 20, 2026 (the “Effective Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | DENTSPLY SIRONA Inc. (XRAY) |
|---|---|
| Event | Appointment |
| Incoming | John C. Fortson |
| Title in the filing | Executive Vice President & Chief Financial Officer |
| Effective | July 20, 2026 |
| 8-K filed | June 11, 2026 |
| Internal promotion | No |
| Prior role (per filing) | President and Chief Financial Officer, Kymera International |
| SEC CIK | 0000818479 |
DENTSPLY SIRONA Inc. reported this change in a Form 8-K, Item 5.02, filed June 11, 2026. The filing's own words are quoted above.
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about John C. Fortson? Send a correction with the primary source.